Postdiagnosis weight change and survival following a diagnosis of early-stage breast cancer
EM Cespedes Feliciano, CH Kroenke… - … Biomarkers & Prevention, 2017 - AACR
Background: Achieving a healthy weight is recommended for all breast cancer survivors.
Previous research on postdiagnosis weight change and mortality had conflicting results …
Previous research on postdiagnosis weight change and mortality had conflicting results …
[HTML][HTML] Sex-specific differences in cardiovascular risk, risk factors and risk management in the peripheral arterial disease population
AL Pouncey, M Woodward - Diagnostics, 2022 - mdpi.com
Cardiovascular disease (CVD) is the leading cause of mortality in women worldwide but has
been primarily recognised as a man's disease. The major components of CVD are …
been primarily recognised as a man's disease. The major components of CVD are …
[HTML][HTML] A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with …
E Díaz-Balboa, V González-Salvado… - BMC cardiovascular …, 2021 - Springer
Background Anthracyclines and monoclonal antibodies against human epidermal growth
factor receptor-2 (HER2) are frequently used to treat breast cancer but they are associated …
factor receptor-2 (HER2) are frequently used to treat breast cancer but they are associated …
Physical activity and quality of life in African American cancer survivors: the Detroit Research on Cancer Survivors study
JL Beebe‐Dimmer, JJ Ruterbusch, FWK Harper… - Cancer, 2020 - Wiley Online Library
Background The benefit of regular exercise in improving cancer outcomes is well
established. The American Cancer Society (ACS) released a recommendation that cancer …
established. The American Cancer Society (ACS) released a recommendation that cancer …
[HTML][HTML] Cardioprotective effects of exercise training on doxorubicin-induced cardiomyopathy: a systematic review with meta-analysis of preclinical studies
PVC Ghignatti, LJ Nogueira, AM Lehnen… - Scientific reports, 2021 - nature.com
Doxorubicin (DOX)-induced cardiotoxicity in chemotherapy is a major treatment drawback.
Clinical trials on the cardioprotective effects of exercise in cancer patients have not yet been …
Clinical trials on the cardioprotective effects of exercise in cancer patients have not yet been …
[HTML][HTML] A whole-food, plant-based randomized controlled trial in metastatic breast cancer: weight, cardiometabolic, and hormonal outcomes
TM Campbell, EK Campbell, E Culakova… - Breast Cancer Research …, 2024 - Springer
Purpose Breast cancer treatment is associated with weight gain, and obesity and its related
cardiometabolic and hormonal risk factors have been associated with poorer outcomes …
cardiometabolic and hormonal risk factors have been associated with poorer outcomes …
[HTML][HTML] Metformin use correlated with lower risk of cardiometabolic diseases and related mortality among US cancer survivors: evidence from a nationally …
Y Li, X Liu, W Lv, X Wang, Z Du, X Liu, F Meng, S Jin… - BMC medicine, 2024 - Springer
Background In the USA, the prolonged effective survival of cancer population has brought
significant attention to the rising risk of cardiometabolic morbidity and mortality in this …
significant attention to the rising risk of cardiometabolic morbidity and mortality in this …
Candesartan and carvedilol for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin
M Lee, WB Chung, J Lee, CS Park, WC Park… - Cancer …, 2021 - Wiley Online Library
Background There is no proven primary preventive strategy for doxorubicin‐induced
subclinical cardiotoxicity (DISC), especially among patients without a cardiovascular (CV) …
subclinical cardiotoxicity (DISC), especially among patients without a cardiovascular (CV) …
Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer
AN Troeschel, Y Liu, LJ Collin… - International journal …, 2019 - academic.oup.com
Background Breast cancer (BC) survivors are at increased risk of cardiovascular disease
(CVD) due to shared risk factors with BC and cardiotoxic treatment effects. We aim to …
(CVD) due to shared risk factors with BC and cardiotoxic treatment effects. We aim to …
Cardiovascular and other competing causes of death among patients with cancer from 2006 to 2015: an Australian population‐based study
Background With improved cancer survivorship, cardiovascular disease (CVD) and other
noncancer events compete with cancer as the underlying cause of death, but the risks of …
noncancer events compete with cancer as the underlying cause of death, but the risks of …